Discovery of 1,3-Diphenyl-1h-pyrazole Derivatives Containing Rhodanine-3-alkanoic Acid Groups As Potential PTP1B Inhibitors.

Liangpeng Sun,Peipei Wang,Lili Xu,Lixin Gao,Jia Li,Huri Piao
DOI: https://doi.org/10.1016/j.bmcl.2019.03.023
IF: 2.94
2019-01-01
Bioorganic & Medicinal Chemistry Letters
Abstract:Two series of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups were identified as competitive protein tyrosine phosphatase 1B (PTP1B) inhibitors. Among the compounds studied, IIIv was found to have the best in vitro inhibition activity against PTP1B (IC50 = 0.67 +/- 0.09 mu M) and the best selectivity (9-fold) between PTP1B and T-cell protein tyrosine phosphatase (TCPTP). Molecular docking studies demonstrated that compounds IIIm, IIIv and IVg could occupy simultaneously at both the catalytic site and the adjacent pTyr binding site. These results provide novel lead compounds for the design of inhibitors of PTP1B as well as other PTPs.
What problem does this paper attempt to address?